Skip to content

Spero Therapeutics, Inc.

SPRO· NasdaqCore metricsCIK 1701108

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -3.23%
Market cap
$58.07M
58.26M shares
Filings
521
$0.00
Q3 2026+3,292.5% FY25 yoy
-$44.28M
Q3 2026N/M FY25 yoy
-$41.91M
Q3 2026N/M FY25 yoy
-$37.00M
Q3 2021derivedN/M FY20 yoy
-$0.76
Q3 2026N/M FY25 yoy
$107.93M
Q3 2026−23.9% FY25 yoy
$58.07M
—
4.6×
74.4×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$0.996761.96%$1.6233past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$12.59MFY 2025
$12.59M0FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$12,586,000reported
FY 20242024-12-31$371,000reported
FY 20232023-12-31$933,000reported
FY 20222022-12-31$2,503,000 revisedreported
FY 20212021-12-31$3,070,000reported
FY 20202020-12-31$258,000reported
FY 20192019-12-31$4,742,000reported
FY 20182018-12-31$3,966,000reported
FY 20172017-12-31$1,979,000reported
FY 20162016-12-31$335,000reported

Segments

Products
Revenue by Products, FY2023 to FY2025FY2023Collaboration revenue - related party · FY2023 · $95.80MCollaboration revenue · FY2023 · $933.00KGrant Revenue · FY2023 · $7.05MFY2024Collaboration revenue - related party · FY2024 · $27.03MCollaboration revenue · FY2024 · $371.00KGrant Revenue · FY2024 · $20.58MFY2025Collaboration revenue - related party · FY2025 · $47.03MCollaboration revenue · FY2025 · $12.59MGrant Revenue · FY2025 · $7.18M
LineFY2025ShareChange
Collaboration revenue - related party$47.03M70%+74.0%
Collaboration revenue$12.59M19%+3,292.5%
Grant Revenue$7.18M11%−65.1%
Total$66.80M

From the 10-K filed Mar 26, 2026SPRO

Pharmaceutical preparations

Spero Therapeutics, Inc. is the 326th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Spero Therapeutics, Inc. · CIK 1701108 · Engraved from SEC EDGAR